Joel Desharnais

974 total citations
14 papers, 676 citations indexed

About

Joel Desharnais is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Joel Desharnais has authored 14 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Joel Desharnais's work include Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (4 papers) and Chemical Synthesis and Analysis (3 papers). Joel Desharnais is often cited by papers focused on Biochemical and Molecular Research (6 papers), HIV/AIDS drug development and treatment (4 papers) and Chemical Synthesis and Analysis (3 papers). Joel Desharnais collaborates with scholars based in United States. Joel Desharnais's co-authors include Dale L. Boger, Joel Goldberg, Peter K. Vogt, Thorsten Berg, Steven B. Cohen, Daniel Maslyar, Ian A. Wilson, Ali Tavassoli, Stephen J. Benkovic and Qing Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Joel Desharnais

14 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Desharnais United States 11 508 205 129 52 47 14 676
Arwin Aban United States 9 575 1.1× 211 1.0× 165 1.3× 18 0.3× 43 0.9× 13 748
Jong Sung Koh South Korea 17 542 1.1× 284 1.4× 196 1.5× 35 0.7× 48 1.0× 36 923
K. M. Błażewska Poland 19 433 0.9× 288 1.4× 315 2.4× 39 0.8× 89 1.9× 43 962
Paul J. Kleindl United States 14 378 0.7× 207 1.0× 214 1.7× 21 0.4× 111 2.4× 19 697
Konstantinos Kiakos United Kingdom 15 523 1.0× 228 1.1× 299 2.3× 40 0.8× 68 1.4× 43 890
John P. Bingham United Kingdom 14 281 0.6× 218 1.1× 176 1.4× 18 0.3× 40 0.9× 22 531
Tammy L. Bush United States 14 497 1.0× 101 0.5× 156 1.2× 22 0.4× 41 0.9× 30 750
Joel Goldberg United States 18 665 1.3× 516 2.5× 186 1.4× 66 1.3× 83 1.8× 25 1.1k
Ferdinando Maria Milazzo Italy 15 448 0.9× 218 1.1× 163 1.3× 26 0.5× 50 1.1× 30 692
Göran Dahl Sweden 14 462 0.9× 78 0.4× 147 1.1× 41 0.8× 91 1.9× 22 677

Countries citing papers authored by Joel Desharnais

Since Specialization
Citations

This map shows the geographic impact of Joel Desharnais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Desharnais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Desharnais more than expected).

Fields of papers citing papers by Joel Desharnais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Desharnais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Desharnais. The network helps show where Joel Desharnais may publish in the future.

Co-authorship network of co-authors of Joel Desharnais

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Desharnais. A scholar is included among the top collaborators of Joel Desharnais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Desharnais. Joel Desharnais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Browne, Cecille D., et al.. (2017). Abstract 2758: Comparison of cell-free DNA blood collection tubes. Cancer Research. 77(13_Supplement). 2758–2758. 4 indexed citations
2.
Zhong, Xiaotian, Elizabeth Kieras, Eric Sousa, et al.. (2012). Pyroglutamate and O-Linked Glycan Determine Functional Production of Anti-IL17A and Anti-IL22 Peptide-Antibody Bispecific Genetic Fusions. Journal of Biological Chemistry. 288(2). 1409–1419. 15 indexed citations
3.
Ballatore, Carlo, Joel Desharnais, Philip Goelet, et al.. (2006). Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells. Bioorganic & Medicinal Chemistry Letters. 16(19). 5194–5198. 16 indexed citations
4.
Ballatore, Carlo, et al.. (2005). A facile route to paclitaxel C-10 carbamates. Bioorganic & Medicinal Chemistry Letters. 15(10). 2477–2480. 8 indexed citations
5.
Boger, Dale L., et al.. (2003). Solution‐Phase Combinatorial Libraries: Modulating Cellular Signaling by Targeting Protein–Protein or Protein–DNA Interactions. Angewandte Chemie International Edition. 42(35). 4138–4176. 151 indexed citations
6.
Marsilje, Thomas H., Michael P. Hedrick, Joel Desharnais, et al.. (2003). 10-(2-Benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid. Bioorganic & Medicinal Chemistry. 11(20). 4503–4509. 5 indexed citations
7.
Marsilje, Thomas H., Michael P. Hedrick, Joel Desharnais, et al.. (2003). Design, synthesis, and biological evaluation of simplified α-Keto heterocycle, trifluoromethyl ketone, and formyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase. Bioorganic & Medicinal Chemistry. 11(20). 4487–4501. 31 indexed citations
9.
Zhang, Yan, Joel Desharnais, Thomas H. Marsilje, et al.. (2003). Rational Design, Synthesis, Evaluation, and Crystal Structure of a Potent Inhibitor of Human GAR Tfase:  10-(Trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic Acid,. Biochemistry. 42(20). 6043–6056. 43 indexed citations
10.
Desharnais, Joel, Inkyu Hwang, Yan Zhang, et al.. (2003). Design, synthesis and biological evaluation of 10-CF3CO-DDACTHF analogues and derivatives as inhibitors of GAR Tfase and the de novo purine biosynthetic pathway. Bioorganic & Medicinal Chemistry. 11(20). 4511–4521. 13 indexed citations
11.
Marsilje, Thomas H., Marc Labroli, Michael P. Hedrick, et al.. (2002). 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-Formyl-DDACTHF). Bioorganic & Medicinal Chemistry. 10(8). 2739–2749. 13 indexed citations
12.
Berg, Thorsten, Steven B. Cohen, Joel Desharnais, et al.. (2002). Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proceedings of the National Academy of Sciences. 99(6). 3830–3835. 261 indexed citations
13.
Zhang, Yan, Joel Desharnais, S.E. Greasley, et al.. (2002). Crystal Structures of Human GAR Tfase at Low and High pH and with Substrate β-GAR,. Biochemistry. 41(48). 14206–14215. 26 indexed citations
14.
Goldberg, Joel, Qing Jin, Yves Ambroise, et al.. (2001). Erythropoietin Mimetics Derived from Solution Phase Combinatorial Libraries. Journal of the American Chemical Society. 124(4). 544–555. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026